Form 4: Elanco Director Receives Equity Awards
Statement of Changes in Beneficial Ownership
Lawrence Kurzius, a Director at Elanco Animal Health Inc., received deferred stock units and restricted stock units on May 21, 2026, as part of annual equity awards.
Summary
- Lawrence Kurzius, a Director at Elanco Animal Health Inc. (ELAN), was granted equity awards on May 21, 2026.
- The awards include 4,678 deferred stock units (DSUs) and 12,196 restricted stock units (RSUs).
- These grants are described as pro-rated annual equity awards for non-employee directors.
- Following these transactions, Kurzius beneficially owns 136,451 shares from DSUs and 148,647 shares from RSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity awards to a director and does not contain new financial performance data or strategic shifts.
Positives
- Director Lawrence Kurzius received annual equity awards, indicating continued incentive alignment with the company.
- The grants of deferred stock units and restricted stock units suggest a commitment to retaining and motivating key board members.
Future Outlook
This filing does not contain forward-looking statements or guidance; it reports on equity awards granted to a director.
Industry Context
StockSavvy.ai notes that the granting of equity awards to directors is a common practice in the animal health industry to align executive and board interests with shareholder value and to attract and retain talent in a competitive market.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Awards | Grant of deferred stock units and restricted stock units to a non-employee director as an annual equity award. | 05/21/2026 | Standard practice for director compensation, aimed at aligning interests and retention. |
Stakeholder Impact
- Shareholders: The equity awards are a form of compensation that impacts dilution, but are standard for director incentives and aim to align director interests with long-term shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/21/2026 | Earliest transaction date and date of equity award grants. |
| 05/26/2026 | Date of signature for the filing. |
Keywords
Elanco Animal Health, ELAN, Form 4, SEC Filing, Director Equity Awards, Deferred Stock Units, Restricted Stock Units, Beneficial Ownership, Lawrence Kurzius
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.